Is Marksans Pharma Limited stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Marksans Pharma Limited pays dividends. Last time was Saturday 5th of October 2024 where the investors holding the stock on Tuesday 17th of September 2024 were paid INR0.6 per share. Over the last 11 times between 2014 and 2024, Marksans Pharma Limited has paid INR2.19 with an average of INR0.2 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Marksans Pharma Limited 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR15.65, you would have made a profit of INR247.44 per share or 1 581.09%
Yes, the average daily trading liquidity for Marksans Pharma Limited is INR2.94 million. You should therefore be able to get in and out of your positions relatively fast.
Marksans Pharma Limited has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 0.55, the company's ability to pay off the debt is good. Marksans Pharma Limited has a good net profit margin of 14.41% and should have high tolerances against inflation.
We have calculated the inflation risk for Marksans Pharma Limited to be low [0.1 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.